TRASTUZUMAB TRASTUZUMAB trastuzumab, sold under the brand name herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer āđāļāļĄāļŠāļĨāđāļāļ it is
TRASTUZUMAB herceptin (trastuzumab) herceptin was the first her2 targeted therapy for breast cancer it is a monoclonal antibody that binds to her2 receptors present on āļĢāļ°āļāļāļāļēāļāļāļāļāđāļĢāđāļ§ trastuzumab āļāļāļāđāļĄāđāļāļąāđāļ for women with her2 positive metastatic breast cancer, trastuzumab may be given on its own or with other treatments treatment with trastuzumab āļāļēāļāļāļāļāļāļąāļāđāļāļĄāļąāļāļī trastuzumab āđāļāļĄāļŠāļĨāđāļāļ
TRASTUZUMAB comment trastuzumab is a humanized igg1Κ monoclonal antibody targeting her2 annotated peptide sequences for this antibody are available from its imgt mab db āđāļ§āđāļāļŠāļĨāđāļāļāļāļāļāđāļĨāļāđ trastuzumab āđāļĨāđāļāļŠāļāļļāļ nhs medicines information on trastuzumab â what it's used for, side effects, dosage and who can have it trastuzumab āļāļēāļāļāļāļāļāļąāļāđāļāļĄāļąāļāļī